Liothyronine sodium
NDC 70377-115, Liothyronine sodium, tablet, from Biocon Pharma Inc..
- Product NDC
- 70377-115
- Status
- Listed
- Labeler
- Biocon Pharma Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218070
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70377-115 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIOTHYRONINE SODIUM25 ug/1
Pharmacologic classes
Triiodothyronine [CS]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70377-115-11 | 70377011511 | 90 TABLET in 1 BOTTLE (70377-115-11) |
| 70377-115-12 | 70377011512 | 100 TABLET in 1 BOTTLE (70377-115-12) |
| 70377-115-13 | 70377011513 | 1000 TABLET in 1 BOTTLE (70377-115-13) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/21002702-422b-1402-73b8-670314d8e579NADAC price for package 70377011512
GET /v1/drugs/nadac/70377011512
Use it
Look up 70377-115 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70377-115 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70377-115. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.